no more compounding glp 1 drugs FDA says that the GLP-1 shortage is over Safest and Cheapest Compounding Pharmacy

And then there are some more serious reported side effects as well

A change in diabetes drug prescribing led to clinical trials of intranasal insulin administration, followed by insulin sensitizers, including metformin and peroxisome proliferator-activated receptor agonists, followed by incretin mimetics targeting primarily GLP-1R (GLP-1RAs) [106]

Contributions JD, LCA, EG, TH performed experiments

The activation of cAMP-PKA signaling in gut IELs can inhibit the phosphorylation of Zeta-chain-associated protein kinase-70 (ZAP-70), stopping the signal from TCR, resulting in the inhibition of the immunological response of T cells (Wong et al., 2022

Plod on, I guess

they make it clear, bright, and healthy without putting it at danger of long-term damage